サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1401365

皮膚糸状菌性爪水虫治療の世界市場規模調査＆予測：製品タイプ別、投与経路別、種類別、流通チャネル別、地域別分析、2023～2030年

Global Dermatophytic Onychomycosis Treatment Market Size Study & Forecast, by Product Type, By Route of Administration, By Type (Prescribed, Over-the-Counter ), By Distribution Channel, and Regional Analysis, 2023-2030
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
皮膚糸状菌性爪水虫治療の世界市場規模調査＆予測：製品タイプ別、投与経路別、種類別、流通チャネル別、地域別分析、2023～2030年
出版日: 2023年11月15日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

皮膚糸状菌性爪水虫治療の世界市場は、2022年に約46億8,000万米ドルと評価され、予測期間2023～2030年には8.0％以上の健全な成長率で成長すると予測されています。

皮膚糸状菌性爪甲真菌症は、真菌性爪感染症としても知られ、様々な種類の真菌（主に皮膚糸状菌）によって引き起こされる一般的な疾患です。爪が変色し、もろくなり、肥厚します。全世界の真菌感染症の約3分の1を占め、その約70～80％が皮膚糸状菌によるものです。この有病率の増加により、皮膚糸状菌性爪水虫治療の必要性が高まっています。糖尿病患者の増加、皮膚糸状菌性爪真菌症とその治療に対する意識の高まり、局所治療に対する需要の急増は、世界中で市場需要を促進している最も顕著な要因です。

さらに、高齢化人口の増加と世界の爪白癬の有病率の増加が、推定期間中の市場成長を加速させている主要因です。High Prevalence of Mixed Infections in Global Onychomycosis」と題された2020年の記事によると、爪白癬の世界の有病率は約10％と推定され、白癬菌は最も一般的に同定される原因菌です。また、2022年に発表されたNCBIの論文によると、爪真菌症は爪に関連する疾患の約半数を占め、世界人口の約5.5％が罹患しています。さらに、2021年に世界保健機関（WHO）が発表したデータによると、2030年までに世界の約6人に1人が60歳以上の高齢者になるといわれています。60歳以上の高齢者の数は、2020年の10億人から2050年には14億人に増加し、60歳以上の成人の世界人口は2050年には21億人と実質的に倍増すると予測されています。さらに、研究開発に対する政府支援の増加や、新しく革新的な治療法の導入の高まりは、予測期間中にさまざまな有利な機会をもたらします。しかし、治療費の高さと治療の副作用が、2023～2030年の予測期間を通じて市場成長の妨げとなっています。

世界の皮膚糸状菌性爪水虫治療市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカなどです。北米は、研究開発活動への投資の増加、経口抗真菌薬のジェネリックバージョンのイントロダクション、真菌性爪感染症の影響に対する意識の高まりにより、2022年の市場を独占しました。一方、アジア太平洋は予測期間中に最も速いCAGRで成長すると予想されます。医療支出の増加、爪真菌症の有病率の増加、糖尿病患者の増加が、同地域全体の市場需要を大きく押し上げています。

本調査の目的は、近年におけるさまざまなセグメントと国の市場規模を定義し、今後数年間の値を予測することです。本レポートは、調査対象国における産業の質的・量的側面を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

第2章 皮膚糸状菌性爪水虫治療の世界市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 産業の進化
    • 調査範囲
  • 調査対象年
  • 通貨換算レート

第3章 皮膚糸状菌性爪水虫治療の世界市場力学

  • 皮膚糸状菌性爪水虫治療市場の影響分析（2020～2030年）
    • 市場の促進要因
      • 皮膚糸状菌性爪甲真菌症とその治療に対する認知度の向上
      • 高齢化人口の増加
      • 爪白癬の有病率の増加
    • 市場の課題
      • 高額な治療費
      • 治療による副作用
    • 市場機会
      • 研究開発に対する政府支援の増加
      • 新しく革新的な治療法のイントロダクションの増加

第4章 皮膚糸状菌性爪水虫治療の世界市場：産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォース影響分析
  • PEST分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主要投資機会
  • 主要成功戦略
  • COVID-19影響分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 皮膚糸状菌性爪水虫治療の世界市場：製品タイプ別

  • 市場スナップショット
  • 皮膚糸状菌性爪水虫治療の世界市場：製品タイプ別、実績・ポテンシャル分析
  • 皮膚糸状菌性爪水虫治療の世界市場：製品タイプ別、推定・予測、2020～2030年
  • 皮膚糸状菌性爪水虫治療市場、サブセグメント分析
    • 錠剤
    • ネイルペイント

第6章 皮膚糸状菌性爪水虫治療の世界市場：投与経路別

  • 市場スナップショット
  • 皮膚糸状菌性爪水虫治療の世界市場：投与経路別、実績・ポテンシャル分析
  • 皮膚糸状菌性爪水虫治療の世界市場：投与経路別、推定・予測、2020～2030年
  • 皮膚糸状菌性爪水虫治療市場、サブセグメント分析
    • 経口
    • 局所

第7章 皮膚糸状菌性爪水虫治療の世界市場：タイプ別

  • 市場スナップショット
  • 皮膚糸状菌性爪水虫治療の世界市場：タイプ別、実績・ポテンシャル分析
  • 皮膚糸状菌性爪水虫治療の世界市場：タイプ別、推定・予測、2020～2030年
  • 皮膚糸状菌性爪水虫治療市場、サブセグメント分析
    • 処方薬
    • 市販薬（OTC）

第8章 皮膚糸状菌性爪水虫治療市場：流通チャネル別

  • 市場スナップショット
  • 皮膚糸状菌性爪水虫治療の世界市場：流通チャネル別、実績・ポテンシャル分析
  • 皮膚糸状菌性爪水虫治療の世界市場：流通チャネル別、推定・予測、2020～2030年
  • 皮膚糸状菌性爪水虫治療市場、サブセグメント分析
    • 病院薬局
    • 小売薬局
    • オンラインチャネル

第9章 皮膚糸状菌性爪水虫治療の世界市場・地域別分析

  • 主要国
  • 主要新興国
  • 皮膚糸状菌性爪甲真菌症治療市場、地域別市場スナップショット
  • 北米
    • 米国
      • 製品タイプ、推定・予測、2020～2030年
      • 投与経路、推定・予測、2020～2030年
      • タイプ、推定・予測、2020～2030年
      • 流通チャネル、推定・予測、2020～2030年
    • カナダ
  • 欧州の皮膚糸状菌性爪水虫治療市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他の欧州
  • アジア太平洋の皮膚糸状菌性爪水虫治療市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他のアジア太平洋
  • ラテンアメリカの皮膚糸状菌性爪水虫治療市場スナップショット
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • その他の中東とアフリカ

第10章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • Bausch Health Companies Inc.
      • 主要情報
      • 概要
      • 財務（データの入手可能性によります）
      • 製品概要
    • Pfizer Inc.
    • Galderma S.A
    • GlaxoSmithKline plc
    • Janssen Pharmaceuticals, Inc.
    • Cipla Inc.
    • Kaken Pharmaceuticals Co., Ltd.
    • Novan, Inc.
    • Anacor Pharmaceuticals, Inc.
    • Moberg Pharma AB

第11章 調査プロセス

  • 調査プロセス
    • データ鉱業
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
  • 調査前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Dermatophytic Onychomycosis Treatment Market, report scope
  • TABLE 2. Global Dermatophytic Onychomycosis Treatment Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3. Global Dermatophytic Onychomycosis Treatment Market estimates & forecasts by Product Type 2020-2030 (USD Billion)
  • TABLE 4. Global Dermatophytic Onychomycosis Treatment Market estimates & forecasts by Route of Administration 2020-2030 (USD Billion)
  • TABLE 5. Global Dermatophytic Onychomycosis Treatment Market estimates & forecasts by Type 2020-2030 (USD Billion)
  • TABLE 6. Global Dermatophytic Onychomycosis Treatment Market estimates & forecasts by Distribution Channel 2020-2030 (USD Billion)
  • TABLE 7. Global Dermatophytic Onychomycosis Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8. Global Dermatophytic Onychomycosis Treatment Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global Dermatophytic Onychomycosis Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global Dermatophytic Onychomycosis Treatment Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global Dermatophytic Onychomycosis Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global Dermatophytic Onychomycosis Treatment Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global Dermatophytic Onychomycosis Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. Global Dermatophytic Onychomycosis Treatment Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. Global Dermatophytic Onychomycosis Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16. Global Dermatophytic Onychomycosis Treatment Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 17. U.S. Dermatophytic Onychomycosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 18. U.S. Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 19. U.S. Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 20. Canada Dermatophytic Onychomycosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 21. Canada Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 22. Canada Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 23. UK Dermatophytic Onychomycosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 24. UK Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 25. UK Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 26. Germany Dermatophytic Onychomycosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 27. Germany Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 28. Germany Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 29. France Dermatophytic Onychomycosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 30. France Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 31. France Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 32. Italy Dermatophytic Onychomycosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 33. Italy Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 34. Italy Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 35. Spain Dermatophytic Onychomycosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 36. Spain Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 37. Spain Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 38. RoE Dermatophytic Onychomycosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 39. RoE Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 40. RoE Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 41. China Dermatophytic Onychomycosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 42. China Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 43. China Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 44. India Dermatophytic Onychomycosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 45. India Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 46. India Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 47. Japan Dermatophytic Onychomycosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 48. Japan Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 49. Japan Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 50. South Korea Dermatophytic Onychomycosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 51. South Korea Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 52. South Korea Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 53. Australia Dermatophytic Onychomycosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 54. Australia Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 55. Australia Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 56. RoAPAC Dermatophytic Onychomycosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 57. RoAPAC Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 58. RoAPAC Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 59. Brazil Dermatophytic Onychomycosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 60. Brazil Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 61. Brazil Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 62. Mexico Dermatophytic Onychomycosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 63. Mexico Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 64. Mexico Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 65. RoLA Dermatophytic Onychomycosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 66. RoLA Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 67. RoLA Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 68. Saudi Arabia Dermatophytic Onychomycosis Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 69. South Africa Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 70. RoMEA Dermatophytic Onychomycosis Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 71. List of secondary sources, used in the study of global Dermatophytic Onychomycosis Treatment Market
  • TABLE 72. List of primary sources, used in the study of global Dermatophytic Onychomycosis Treatment Market
  • TABLE 73. Years considered for the study
  • TABLE 74. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1. Global Dermatophytic Onychomycosis Treatment Market, research methodology
  • FIG 2. Global Dermatophytic Onychomycosis Treatment Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Dermatophytic Onychomycosis Treatment Market, key trends 2022
  • FIG 5. Global Dermatophytic Onychomycosis Treatment Market, growth prospects 2023-2030
  • FIG 6. Global Dermatophytic Onychomycosis Treatment Market, porters 5 force model
  • FIG 7. Global Dermatophytic Onychomycosis Treatment Market, pest analysis
  • FIG 8. Global Dermatophytic Onychomycosis Treatment Market, value chain analysis
  • FIG 9. Global Dermatophytic Onychomycosis Treatment Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global Dermatophytic Onychomycosis Treatment Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global Dermatophytic Onychomycosis Treatment Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global Dermatophytic Onychomycosis Treatment Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global Dermatophytic Onychomycosis Treatment Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global Dermatophytic Onychomycosis Treatment Market, regional snapshot 2020 & 2030
  • FIG 15. North America Dermatophytic Onychomycosis Treatment Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe Dermatophytic Onychomycosis Treatment Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia pacific Dermatophytic Onychomycosis Treatment Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America Dermatophytic Onychomycosis Treatment Market 2020 & 2030 (USD Billion)
  • FIG 19. Middle East & Africa Dermatophytic Onychomycosis Treatment Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Dermatophytic Onychomycosis Treatment Market is valued at approximately USD 4.68 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 8.0% over the forecast period 2023-2030. Dermatophytic onychomycosis, also known as fungal nail infection, is a common condition caused by various types of fungi, primarily dermatophytes. It affects the nails, causing them to become discolored, brittle, and thickened. It constitutes approximately one-third of all fungal infections worldwide, with dermatophytes responsible for around 70%-80% of these cases. This growing prevalence has led to a rising need for medications designed to treat dermatophytic onychomycosis. The growing cases of diabetes, increasing awareness of dermatophytic onychomycosis and its treatment, as well as surging demand for topical treatments are the most prominent factors that are propelling the market demand across the globe.

In addition, the increasing aging population, coupled with the growing prevalence of onychomycosis globally are the leading factors that are accelerating the market growth during the estimated period. According to a 2020 article titled "High Prevalence of Mixed Infections in Global Onychomycosis," the global prevalence of onychomycosis is estimated to be around 10%, with Trichophyton rubrum being the most commonly identified causative organism. Also, as per the NCBI article published in 2022, onychomycosis accounts for roughly half of all nail-related disorders and affects approximately 5.5% of the global population. Furthermore, data from the World Health Organization (WHO) in 2021 indicates that by 2030, approximately one in every six individuals globally will be aged 60 years or older. The number of individuals aged 60 and above is projected to increase from 1 billion in 2020 to 1.4 billion by 2050, effectively doubling the global population of adults aged 60 and over to 2.1 billion by 2050. Moreover, the increasing government support for research and development, as well as the rising introduction of new and innovative treatments presents various lucrative opportunities over the forecast years. However, the high cost of treatment and the side effects of treatment are hindering the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Dermatophytic Onychomycosis Treatment Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the growing investment in R&D activities, the introduction of generic versions of oral antifungal medications, along with the growing awareness about the impact of fungal nail infections. Whereas, Asia Pacific is expected to grow at the fastest CAGR over the forecast years. The rising healthcare expenditure, increasing prevalence of onychomycosis, and diabetic patient populations are significantly propelling the market demand across the region.

Major market players included in this report are:

  • Bausch Health Companies Inc.
  • Pfizer Inc.
  • Galderma S.A
  • GlaxoSmithKline plc
  • Janssen Pharmaceuticals, Inc.
  • Cipla Inc.
  • Kaken Pharmaceuticals Co., Ltd.
  • Novan, Inc.
  • Anacor Pharmaceuticals, Inc.
  • Moberg Pharma AB

Recent Developments in the Market:

  • In July 2021, Kaken Pharmaceutical and Almirall S.A. signed a license and distribution agreement to give Almirall the rights to produce and market the topical antifungal efinaconazole in Europe. The objective of this initiative is to increase the company's geographic reach in Europe.
  • In July 2021, Zydus Lifesciences secured approval from the U.S. FDA to market efinaconazole topical solution for the management of onychomycosis. This regulatory milestone bolstered the company's presence and market position in the United States.

Global Dermatophytic Onychomycosis Treatment Market Report Scope:

  • Historical Data - 2020 - 2021
  • Base Year for Estimation - 2022
  • Forecast period - 2023-2030
  • Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered - Product Type, Route of Administration, Type, Distribution Channel, Region
  • Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Type:

  • Tablets
  • Nail Paints

By Route of Administration:

  • Oral
  • Topical

By Type:

  • Prescribed
  • Over-the-Counter (OTC)

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Channels

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Dermatophytic Onychomycosis Treatment Market, by region, 2020-2030 (USD Billion)
    • 1.2.2. Dermatophytic Onychomycosis Treatment Market, by Product Type, 2020-2030 (USD Billion)
    • 1.2.3. Dermatophytic Onychomycosis Treatment Market, by Route of Administration, 2020-2030 (USD Billion)
    • 1.2.4. Dermatophytic Onychomycosis Treatment Market, by Type, 2020-2030 (USD Billion)
    • 1.2.5. Dermatophytic Onychomycosis Treatment Market, by Distribution Channel, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Dermatophytic Onychomycosis Treatment Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Dermatophytic Onychomycosis Treatment Market Dynamics

  • 3.1. Dermatophytic Onychomycosis Treatment Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing awareness of dermatophytic onychomycosis and its treatment
      • 3.1.1.2. Rising aging population
      • 3.1.1.3. Growing prevalence of onychomycosis
    • 3.1.2. Market Challenges
      • 3.1.2.1. High cost of treatment
      • 3.1.2.2. Side effects of treatment
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increasing government support for research and development
      • 3.1.3.2. Rising introduction of new and innovative treatments

Chapter 4. Global Dermatophytic Onychomycosis Treatment Market: Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economic
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Dermatophytic Onychomycosis Treatment Market, by Product Type

  • 5.1. Market Snapshot
  • 5.2. Global Dermatophytic Onychomycosis Treatment Market by Product Type, Performance - Potential Analysis
  • 5.3. Global Dermatophytic Onychomycosis Treatment Market Estimates & Forecasts by Product Type 2020-2030 (USD Billion)
  • 5.4. Dermatophytic Onychomycosis Treatment Market, Sub Segment Analysis
    • 5.4.1. Tablets
    • 5.4.2. Nail Paints

Chapter 6. Global Dermatophytic Onychomycosis Treatment Market, by Route of Administration

  • 6.1. Market Snapshot
  • 6.2. Global Dermatophytic Onychomycosis Treatment Market by Route of Administration, Performance - Potential Analysis
  • 6.3. Global Dermatophytic Onychomycosis Treatment Market Estimates & Forecasts by Route of Administration 2020-2030 (USD Billion)
  • 6.4. Dermatophytic Onychomycosis Treatment Market, Sub Segment Analysis
    • 6.4.1. Oral
    • 6.4.2. Topical

Chapter 7. Global Dermatophytic Onychomycosis Treatment Market, by Type

  • 7.1. Market Snapshot
  • 7.2. Global Dermatophytic Onychomycosis Treatment Market by Type, Performance - Potential Analysis
  • 7.3. Global Dermatophytic Onychomycosis Treatment Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
  • 7.4. Dermatophytic Onychomycosis Treatment Market, Sub Segment Analysis
    • 7.4.1. Prescribed
    • 7.4.2. Over-the-Counter (OTC)

Chapter 8. Dermatophytic Onychomycosis Treatment Market, by Distribution Channel

  • 8.1. Market Snapshot
  • 8.2. Global Dermatophytic Onychomycosis Treatment Market by Distribution Channel, Performance - Potential Analysis
  • 8.3. Global Dermatophytic Onychomycosis Treatment Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
  • 8.4. Dermatophytic Onychomycosis Treatment Market, Sub Segment Analysis
    • 8.4.1. Hospital Pharmacies
    • 8.4.2. Retail Pharmacies
    • 8.4.3. Online Channels

Chapter 9. Global Dermatophytic Onychomycosis Treatment Market, Regional Analysis

  • 9.1. Top Leading Countries
  • 9.2. Top Emerging Countries
  • 9.3. Dermatophytic Onychomycosis Treatment Market, Regional Market Snapshot
  • 9.4. North America Dermatophytic Onychomycosis Treatment Market
    • 9.4.1. U.S. Dermatophytic Onychomycosis Treatment Market
      • 9.4.1.1. Product Type breakdown estimates & forecasts, 2020-2030
      • 9.4.1.2. Route of Administration breakdown estimates & forecasts, 2020-2030
      • 9.4.1.3. Type breakdown estimates & forecasts, 2020-2030
      • 9.4.1.4. Distribution Channel breakdown estimates & forecasts, 2020-2030
    • 9.4.2. Canada Dermatophytic Onychomycosis Treatment Market
  • 9.5. Europe Dermatophytic Onychomycosis Treatment Market Snapshot
    • 9.5.1. U.K. Dermatophytic Onychomycosis Treatment Market
    • 9.5.2. Germany Dermatophytic Onychomycosis Treatment Market
    • 9.5.3. France Dermatophytic Onychomycosis Treatment Market
    • 9.5.4. Spain Dermatophytic Onychomycosis Treatment Market
    • 9.5.5. Italy Dermatophytic Onychomycosis Treatment Market
    • 9.5.6. Rest of Europe Dermatophytic Onychomycosis Treatment Market
  • 9.6. Asia-Pacific Dermatophytic Onychomycosis Treatment Market Snapshot
    • 9.6.1. China Dermatophytic Onychomycosis Treatment Market
    • 9.6.2. India Dermatophytic Onychomycosis Treatment Market
    • 9.6.3. Japan Dermatophytic Onychomycosis Treatment Market
    • 9.6.4. Australia Dermatophytic Onychomycosis Treatment Market
    • 9.6.5. South Korea Dermatophytic Onychomycosis Treatment Market
    • 9.6.6. Rest of Asia Pacific Dermatophytic Onychomycosis Treatment Market
  • 9.7. Latin America Dermatophytic Onychomycosis Treatment Market Snapshot
    • 9.7.1. Brazil Dermatophytic Onychomycosis Treatment Market
    • 9.7.2. Mexico Dermatophytic Onychomycosis Treatment Market
  • 9.8. Middle East & Africa Dermatophytic Onychomycosis Treatment Market
    • 9.8.1. Saudi Arabia Dermatophytic Onychomycosis Treatment Market
    • 9.8.2. South Africa Dermatophytic Onychomycosis Treatment Market
    • 9.8.3. Rest of Middle East & Africa Dermatophytic Onychomycosis Treatment Market

Chapter 10. Competitive Intelligence

  • 10.1. Key Company SWOT Analysis
    • 10.1.1. Company 1
    • 10.1.2. Company 2
    • 10.1.3. Company 3
  • 10.2. Top Market Strategies
  • 10.3. Company Profiles
    • 10.3.1. Bausch Health Companies Inc.
      • 10.3.1.1. Key Information
      • 10.3.1.2. Overview
      • 10.3.1.3. Financial (Subject to Data Availability)
      • 10.3.1.4. Product Summary
      • 10.3.1.5. Recent Developments
    • 10.3.2. Pfizer Inc.
    • 10.3.3. Galderma S.A
    • 10.3.4. GlaxoSmithKline plc
    • 10.3.5. Janssen Pharmaceuticals, Inc.
    • 10.3.6. Cipla Inc.
    • 10.3.7. Kaken Pharmaceuticals Co., Ltd.
    • 10.3.8. Novan, Inc.
    • 10.3.9. Anacor Pharmaceuticals, Inc.
    • 10.3.10. Moberg Pharma AB

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption